Overcoming cancer therapeutic bottleneck by drug repurposing
Ever present hurdles for the discovery of new drugs for cancer therapy have necessitated
the development of the alternative strategy of drug repurposing, the development of old …
the development of the alternative strategy of drug repurposing, the development of old …
The PTEN conundrum: how to target PTEN-deficient prostate cancer
DJ Turnham, N Bullock, MS Dass, JN Staffurth… - Cells, 2020 - mdpi.com
Loss of the tumor suppressor phosphatase and tensin homologue deleted on chromosome
10 (PTEN), which negatively regulates the PI3K–AKT–mTOR pathway, is strongly linked to …
10 (PTEN), which negatively regulates the PI3K–AKT–mTOR pathway, is strongly linked to …
Phase I trial of ganitumab plus dasatinib to cotarget the insulin-like growth factor 1 receptor and src family kinase YES in rhabdomyosarcoma
S Akshintala, RT Sundby, D Bernstein, JW Glod… - Clinical cancer …, 2023 - AACR
Purpose: Antibodies against insulin-like growth factor (IGF) type 1 receptor have shown
meaningful but transient tumor responses in patients with rhabdomyosarcoma (RMS). The …
meaningful but transient tumor responses in patients with rhabdomyosarcoma (RMS). The …
Emerging role of IGF-1 in prostate cancer: a promising biomarker and therapeutic target
G Liu, M Zhu, M Zhang, F Pan - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer (PCa) affects millions of men globally, and approximately
20% of PCa patients are found after they develop into a lethal metastatic or castration …
20% of PCa patients are found after they develop into a lethal metastatic or castration …
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer
Background This multicentre, open-label, Phase Ib/II trial evaluated the insulin-like growth
factor (IGF) 1/2 neutralising antibody xentuzumab plus enzalutamide in metastatic castrate …
factor (IGF) 1/2 neutralising antibody xentuzumab plus enzalutamide in metastatic castrate …
[HTML][HTML] Targeting the PI3K-AKT-mTOR pathway in castration resistant prostate cancer: a review article
J Cham, AR Venkateswaran, M Bhangoo - Clinical Genitourinary Cancer, 2021 - Elsevier
Background Prostate cancer is one of leading causes of cancer death among men
worldwide. Androgen deprivation therapy is a central part of the prostate cancer treatment …
worldwide. Androgen deprivation therapy is a central part of the prostate cancer treatment …
[HTML][HTML] Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer
M Wylaź, A Kaczmarska, D Pajor, M Hryniewicki… - Biomedicine & …, 2023 - Elsevier
Breast cancer (BC) and prostate cancer (PC) are at the top of the list when it comes to the
most common types of cancers worldwide. The phosphatidylinositol 3-kinase (PI3K)/protein …
most common types of cancers worldwide. The phosphatidylinositol 3-kinase (PI3K)/protein …
Inflammation in urological malignancies: the silent killer
M Catalano, G Roviello, R Santi, D Villari… - International Journal of …, 2023 - mdpi.com
Several studies have investigated the role of inflammation in promoting tumorigenesis and
cancer progression. Neoplastic as well as surrounding stromal and inflammatory cells …
cancer progression. Neoplastic as well as surrounding stromal and inflammatory cells …
Recent advances and future directions in anti‐tumor activity of cryptotanshinone: A mechanistic review
M Ashrafizadeh, A Zarrabi, S Orouei… - Phytotherapy …, 2021 - Wiley Online Library
In respect to the enhanced incidence rate of cancer worldwide, studies have focused on
cancer therapy using novel strategies. Chemotherapy is a common strategy in cancer …
cancer therapy using novel strategies. Chemotherapy is a common strategy in cancer …
The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy
G Lemos, CMAS Fernandes, FH Silva… - Prostate Cancer and …, 2024 - nature.com
Background Autophagy is a well-conserved catabolic process that plays a key role in cell
homeostasis. In the prostate, defective autophagy has been implicated in the genesis and …
homeostasis. In the prostate, defective autophagy has been implicated in the genesis and …